Dysregulation of this signaling pathway in endometrial cancer can lead to transforming tumors into a more aggressive metastatic phenotype; therefore, we performed a study to determine whether GnRH-(1–5) can alter the EGFR signaling pathway in the endometrial cancer Ishikawa cell line (72–75). The gene discussed is EGFR; the disease is endometrial cancer.